The effect of arsenic trioxide on QT interval prolongation during APL therapy

Chinese Medical Journal

Volumn 116, Issue 11, 2003, Pages 1764-1766

  Zhou, Jin ^a   Meng, Ran ^a   Li, Xiaoxia ^a   Lü, Chengfang ^a   Fan, Shengjin ^a   Yang, Baofeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute promyelocytic leukemia; Arsenic trioxide; Electrocardiogram

Indexed keywords

ARSENIC TRIOXIDE; HEMOGLOBIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; ELECTROCARDIOGRAPHY; FLUOROPHOTOMETRY; HEART FUNCTION; HUMAN; PROMYELOCYTIC LEUKEMIA; QT DISPERSION; QT PROLONGATION; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ARSENICALS; ELECTROCARDIOGRAPHY; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES;

EID: 0348156862     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Nin C, Yan H, Yu T, et al. Studies on treatment of acute promyelocytic lenkemia with arsenic trioxide: remission indnction, follow-up, and molecular montoring in 11 newly diagnosed and 47 replaced acute promyelocytic lenkenia patients. Blood 1999;94:3315-3324.
2. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regula-tory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000;21:1216-1231.
3. Camm AJ, Janse MJ, Roden DM, et al. Congenital and acquired long QT syndrome. Eur Heart J 2000;21:1232-1237.
4. Mitcheson JS, Chen J, Lin M, et al. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A 2000;97:12329-12333.